Filtration disrupts synaptosomes during radiochemical analysis of serotonin uptake: Comparison with chronoamperometry in SERT knockout mice

Journal of Neuroscience Methods

Volumn 154, Issue 1-2, 2006, Pages 245-255

  Perez, Xiomara A ^a   Bianco, Laura E ^a   Andrews, Anne M ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Chronoamperometry; Knockout mice; Radiochemical assay; Serotonin; Serotonin transporter; Uptake

Indexed keywords

BUFFER; OXYGEN; SEROTONIN; SEROTONIN RECEPTOR; TRITIUM;

AMPEROMETRY; ANIMAL TISSUE; ARTICLE; BRAIN STEM; BRAIN SYNAPTOSOME; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; CORPUS STRIATUM; FRONTAL CORTEX; INCUBATION TIME; INTERMETHOD COMPARISON; ISOTOPE LABELING; KNOCKOUT MOUSE; MEMBRANE FILTER; MOUSE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RADIOASSAY; RADIOSENSITIVITY; SEROTONIN UPTAKE;

ALGORITHMS; ANIMALS; AUTORADIOGRAPHY; BRAIN; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; ELECTRODES; FILTRATION; KINETICS; MICE; MICE, KNOCKOUT; RADIOCHEMISTRY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMES;

EID: 33744542837     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2005.12.017     Document Type: Article

References (55)

1. Adams R.N. Probing brain chemistry with electroanalytical techniques. Anal Chem 48 (1976) 1126A-1138A
2. Andrews A.M., and Murphy D.L. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2′-aminophenyl)-1,2,3,6-tetrahydropyridine (2′-NH2-MPTP): a comparative study with 2′-CH3-MPTP and MPTP. J Neurochem 60 (1993) 1167-1170
3. Andrews A.M., Ladenheim B., Epstein C.J., Cadet J.L., and Murphy D.L. Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2′-NH2-MPTP on serotonergic and noradrenergic nerve terminals. Mol Pharmacol 50 (1996) 1511-1519
4. Beckman M.L., and Quick M.W. Neurotransmitter transporters: regulators of function and functional regulation. J Membr Biol 164 (1998) 1-10
5. Bengel D., Johren O., Andrews A.M., Heils A., Mossner R., Sanvitto G.L., Saavedra J.M., Lesch K.P., and Murphy D.L. Cellular localization and expression of the serotonin transporter in mouse brain. Brain Res 778 (1997) 338-345
6. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mossner R., Westphal H., and Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53 (1998) 649-655
7. Blakely R.D., and Bauman A.L. Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol 10 (2000) 328-336
8. Blakely R.D., De Felice L.J., and Hartzell H.C. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196 (1994) 263-281
9. Bradford H.F. Respiration in vitro of synaptosomes from mammalian cerebral cortex. J Neurochem 16 (1969) 675-684
10. Bunin M.A., Prioleau C., Mailman R.B., and Wightman R.M. Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain. J Neurochem 70 (1998) 1077-1087
11. Coccaro E.F., and Murphy D.L. Serotonin in Major Psychiatric Disorders (1990), American Psychiatric Press, Inc., Washington, DC
12. Daws L.C., Toney G.M., Gerhardt G.A., and Frazer A. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther 286 (1998) 967-976
13. Earles C., and Schenk J.O. Rotating disk electrode voltammetric measurements of dopamine transporter activity: an analytical evaluation. Anal Biochem 264 (1998) 191-198
14. Fernandez F., Sarre S., Launay J.M., Aguerre S., Guyonnet-Duperat V., Moisan M.P., Ebinger G., Michotte Y., Mormede P., and Chaouloff F. Rat strain differences in peripheral and central serotonin transporter protein expression and function. Eur J Neurosci 17 (2003) 494-506
15. Gerhardt G.A. Rapid chronocoulometric meausurements of norepinephrine overflow and clearance in CNS tissues. Neuromethods: Voltammetric Methods in Brain Systems, vol. 27 (1995) pp. 117-50
16. Gerhardt G.A., Oke A.F., Nagy G., Moghaddam B., and Adams R.N. Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res 290 (1984) 390-395
17. Ghijsen W.E., Leenders A.G., and Lopes da Silva F.H. Regulation of vesicle traffic and neurotransmitter release in isolated nerve terminals. Neurochem Res 28 (2003) 1443-1452
18. Gray E.G., and Whittaker V.P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96 (1962) 79-88
19. Greenberg B.D., Li Q., Lucas F.R., Hu S., Sirota L.A., Benjamin J., Lesch K.P., Hamer D., and Murphy D.L. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96 (2000) 202-216
20. Hebb C.O., and Whittaker V.P. Intracellular distributions of acetylcholine and choline acetylase. J Physiol 142 (1958) 187-196
21. Holmes A., Murphy D.L., and Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 161 (2002) 160-167
22. Holmes A., Yang R.J., Murphy D.L., and Crawley J.N. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27 (2002) 914-923
23. Holmes A., Murphy D.L., and Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry 54 (2003) 953-959
24. Holmes A., Yang R.J., Lesch K.P., Crawley J.N., and Murphy D.L. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28 (2003) 2077-2088
25. Hyde C.E., and Bennett B.A. Similar properties of fetal and adult amine transporters in the rat brain. Brain Res 646 (1994) 118-123
26. Inazu M., Takeda H., Ikoshi H., Sugisawa M., Uchida Y., and Matsumiya T. Pharmacological characterization and visualization of the glial serotonin transporter. Neurochem Int 39 (2001) 39-49
27. Johnson M.K., and Whittaker V.P. Lactate dehydrogenase as a cytoplasmic marker in brain. Biochem J 88 (1963) 404-409
28. Kilic F., Murphy D.L., and Rudnick G. A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64 (2003) 440-446
29. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
30. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
31. Mager S., Min C., Henry D.J., Chavkin C., Hoffman B.J., Davidson N., and Lester H.A. Conducting states of a mammalian serotonin transporter. Neuron 12 (1994) 845-859
32. Mathews T.A., Fedele D.E., Coppelli F.E., Avila A.M., Murphy D.L., and Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 140 (2004) 169-181
33. Michael D.J., and Wightman R.M. Electrochemical monitoring of biogenic amine neurotransmission in real time. J Pharm Biomed Anal 19 (1999) 33-46
34. Montanez S., Owens W.A., Gould G.G., Murphy D.L., and Daws L.C. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J Neurochem 86 (2003) 210-219
35. Murphy D.L., Andrews A.M., Wichems C.H., Li Q., Tohda M., and Greenberg B. Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs. J Clin Psychiatry 59 Suppl 15 (1998) 4-12
36. Murphy D.L., Li Q., Engel S., Wichems C., Andrews A., Lesch K.P., and Uhl G. Genetic perspectives on the serotonin transporter. Brain Res Bull 56 (2001) 487-494
37. 3H]serotonin into plasma membrane vesicles from mouse cerebral cortex. J Biol Chem 263 (1988) 6115-6121
38. Ozaki N., Goldman D., Kaye W.H., Plotnicov K., Greenberg B.D., Lappalainen J., Rudnick G., and Murphy D.L. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8 895 (2003) 896-933
39. Perez X.A., and Andrews A.M. Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice. Anal Chem 77 (2005) 818-826
40. Prasad H.C., Zhu C.B., McCauley J.L., Samuvel D.J., Ramamoorthy S., Shelton R.C., Hewlett W.A., Sutcliffe J.S., and Blakely R.D. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci USA 102 (2005) 1545-1550
41. Reith M.E., and O'Reilly C.A. Inhibition of serotonin uptake into mouse brain synaptosomes by ionophores and ion-channel agents. Brain Res 521 (1990) 347-351
42. Reith M.E., Zimanyi I., and O'Reilly C.A. Role of ions and membrane potential in uptake of serotonin into plasma membrane vesicles from mouse brain. Biochem Pharmacol 38 (1989) 2091-2097
43. Reyes-Haro D., Garcia-Alcocer G., Miledi R., and Garcia-Colunga J. Uptake of serotonin by adult rat corpus callosum is partially reduced by common antidepressants. J Neurosci Res 74 (2003) 97-102
44. Richelson E. Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. J Clin Psychiatry 64 Suppl. 13 (2003) 5-12
45. Rothman R.B., and Baumann M.H. Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav 71 (2002) 825-836
46. Rudnick G., and Clark J. From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144 (1993) 249-263
47. Schenk J.O., Miller E., Rice M.E., and Adams R.N. Chronoamperometry in brain slices: quantitative evaluations of in vivo electrochemistry. Brain Res 277 (1983) 1-8
48. Schinka J.A., Busch R.M., and Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 9 (2004) 197-202
49. Sen S., Burmeister M., and Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127 (2004) 85-89
50. 125I]RTI-55 associated with the 5-HT transporter in rat brain membranes. J Pharmacol Exp Ther 273 (1995) 213-222
51. Sutcliffe J.S., Delahanty R.J., Prasad H.C., McCauley J.L., Han Q., Jiang L., Li C., Folstein S.E., and Blakely R.D. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77 (2005) 265-279
52. Troyer K.P., Heien M.L., Venton B.J., and Wightman R.M. Neurochemistry and electroanalytical probes. Curr Opin Chem Biol 6 (2002) 696-703
53. Whittaker V.P. Thirty years of synaptosome research. J Neurocytol 22 (1993) 735-742
54. Wise R.A. Neurobiology of addiction. Curr Opin Neurobiol 6 (1996) 243-251
55. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92 (2001) 21-55